WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics
Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.
Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:
Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.
More Articles
RSRT Joins 22 Groups to Support Expanded Access to AI Medical Technology
Recently, Right Scan Right Time joined with 22 other patient advocacy groups in signing a letter to Senators Heinrich…
Read MoreNational Oral Cancer Month: Early Detection Saves Lives
April is Oral Cancer Awareness Month – an opportunity to raise awareness about the serious and deadly effects…
Read MoreHealth Tech Investment Act Can Improve Patient Care
The future of healthcare is here – and Artificial Intelligence (AI) is at the forefront. Already, AI-enabled medical…
Read MoreNational Colorectal Cancer Awareness Month: The Importance of Early Detection
Every March, we recognize National Colorectal Cancer Awareness Month as an opportunity to raise awareness about this all-too-common…
Read More